SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-21-000009
Filing Date
2021-08-12
Accepted
2021-08-12 12:20:06
Documents
84
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20210630x10q.htm   iXBRL 10-Q 3506517
2 EX-31.1 veru-20210630xex31_1.htm EX-31.1 15767
3 EX-31.2 veru-20210630xex31_2.htm EX-31.2 15992
4 EX-32.1 veru-20210630xex32_1.htm EX-32.1 11824
  Complete submission text file 0000863894-21-000009.txt   13260373

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20210630.xsd EX-101.SCH 66236
6 EX-101.CAL veru-20210630_cal.xml EX-101.CAL 78291
7 EX-101.DEF veru-20210630_def.xml EX-101.DEF 234480
8 EX-101.LAB veru-20210630_lab.xml EX-101.LAB 503727
9 EX-101.PRE veru-20210630_pre.xml EX-101.PRE 430953
10 EXTRACTED XBRL INSTANCE DOCUMENT veru-20210630x10q_htm.xml XML 3182343
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 211166378
SIC: 2834 Pharmaceutical Preparations